Wed, October 31, 2018
Tue, October 30, 2018
Mon, October 29, 2018
Fri, October 26, 2018
Thu, October 25, 2018
Wed, October 24, 2018
Tue, October 23, 2018
Mon, October 22, 2018
Fri, October 19, 2018
Thu, October 18, 2018

Do Kim Maintained (VRTX) at Buy with Decreased Target to $192 on, Oct 25th, 2018


//stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-192-on-oct-25th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Do Kim of BMO Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Decreased Target from $204 to $192 on, Oct 25th, 2018.

Do has made no other calls on VRTX in the last 4 months.



There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $188 on, Thursday, July 26th, 2018


These are the ratings of the 2 analyists that currently disagree with Do


  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $206 on, Monday, July 30th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $211 on, Thursday, July 26th, 2018

Publication Contributing Sources